Financial
Parent Experian (EXPN.L) group FY2026 revenue $8.45bn (+12.3%); operating margin 24.2%.
Benchmark EBIT $2.40bn (+15%); net debt 1.7x Benchmark EBITDA.
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Parent Experian (EXPN.L) group FY2026 revenue $8.45bn (+12.3%); operating margin 24.2%.
Benchmark EBIT $2.40bn (+15%); net debt 1.7x Benchmark EBITDA.
Source: official results release · Year ended 2026-03-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2026 | US$8.4bn | +12.3% | US$2bn | — | Experian group |
Products not yet catalogued.
Parent Experian (EXPN.L) group FY2026 revenue $8.45bn (+12.3%); operating margin 24.2%.
Benchmark EBIT $2.40bn (+15%); net debt 1.7x Benchmark EBITDA.
No material adverse media (litigation, regulator action, restructuring or financial distress) involving Experian Health found in HSH's search of the last 24 months.
No data breaches, cyber incidents or regulator actions involving Experian Health found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Revenue cycle and patient access software supplier; no regulatory or clinical safety actions found in the last 24 months.
Oct 2026: Experian Health acquired eInsights to expand its insurance discovery and reimbursement capabilities. No contract disputes or troubled implementations involving Experian Health found in HSH's search of the last 24 months.
No competitors linked yet.